{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:50:03Z","timestamp":1792511403439,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7633","license":[{"start":{"date-parts":[[2016,11,7]],"date-time":"2016-11-07T00:00:00Z","timestamp":1478476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,11,7]],"date-time":"2016-11-07T00:00:00Z","timestamp":1478476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2016,12,15]]},"DOI":"10.1038\/nature20564","type":"journal-article","created":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T08:38:56Z","timestamp":1478248736000},"page":"443-447","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":396,"title":["Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice"],"prefix":"10.1038","volume":"540","author":[{"given":"Gopal","family":"Sapparapu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefania","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurgun","family":"Kose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Bin Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin G.","family":"Bombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubrey L.","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira U.","family":"Mysorekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daved H.","family":"Fremont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Doranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,7]]},"reference":[{"key":"BFnature20564_CR1","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nrmicro.2016.125","volume":"14","author":"CB Coyne","year":"2016","unstructured":"Coyne, C. B. & Lazear, H. M. Zika virus\u2014reigniting the TORCH. Nat. Rev. Microbiol. 14, 707\u2013715 (2016)","journal-title":"Nat. Rev. Microbiol."},{"key":"BFnature20564_CR2","first-page":"7","volume":"19","author":"E Oehler","year":"2014","unstructured":"Oehler, E. et al. Zika virus infection complicated by Guillain-Barr\u00e9 syndrome\u2013case report, French Polynesia, December 2013. Eur. Commun. Dis. Bull. 19, 7\u20139 (2014)","journal-title":"Eur. Commun. Dis. Bull."},{"key":"BFnature20564_CR3","doi-asserted-by":"publisher","first-page":"O595","DOI":"10.1111\/1469-0691.12707","volume":"20","author":"D Musso","year":"2014","unstructured":"Musso, D., Nilles, E. J. & Cao-Lormeau, V. M. Rapid spread of emerging Zika virus in the Pacific area. Clin. Microbiol. Infect. 20, O595\u2013O596 (2014)","journal-title":"Clin. Microbiol. Infect."},{"key":"BFnature20564_CR4","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1093\/brain\/aww158","volume":"139","author":"AQC Araujo","year":"2016","unstructured":"Araujo, A. Q. C., Silva, M. T. T. & Araujo, A. P. Q. C. Zika virus-associated neurological disorders: a review. Brain 139, 2122\u20132130 (2016)","journal-title":"Brain"},{"key":"BFnature20564_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1099\/jgv.0.000381","volume":"97","author":"D Gatherer","year":"2016","unstructured":"Gatherer, D. & Kohl, A. Zika virus: a previously slow pandemic spreads rapidly through the Americas. J. Gen. Virol. 97, 269\u2013273 (2016)","journal-title":"J. Gen. Virol."},{"key":"BFnature20564_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/imm.12323","volume":"143","author":"E Davidson","year":"2014","unstructured":"Davidson, E. & Doranz, B. J. A high-throughput shotgun mutagenesis approach to mapping B-cell antibody epitopes. Immunology 143, 13\u201320 (2014)","journal-title":"Immunology"},{"key":"BFnature20564_CR7","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2016.07.020","volume":"166","author":"H Zhao","year":"2016","unstructured":"Zhao, H. et al. Structural basis of Zika virus-specific antibody protection. Cell 166, 1016\u20131027 (2016)","journal-title":"Cell"},{"key":"BFnature20564_CR8","doi-asserted-by":"publisher","first-page":"e01559","DOI":"10.1128\/mBio.01559-15","volume":"6","author":"KA Dowd","year":"2015","unstructured":"Dowd, K. A., DeMaso, C. R. & Pierson, T. C. Genotypic differences in dengue virus neutralization are explained by a single amino acid mutation that modulates virus breathing. MBio 6, e01559\u2013159 (2015)","journal-title":"MBio"},{"key":"BFnature20564_CR9","doi-asserted-by":"publisher","first-page":"11726","DOI":"10.1128\/JVI.01140-14","volume":"88","author":"KA Dowd","year":"2014","unstructured":"Dowd, K. A., Mukherjee, S., Kuhn, R. J. & Pierson, T. C. Combined effects of the structural heterogeneity and dynamics of flaviviruses on antibody recognition. J. Virol. 88, 11726\u201311737 (2014)","journal-title":"J. Virol."},{"key":"BFnature20564_CR10","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.aaf8505","volume":"353","author":"K Stettler","year":"2016","unstructured":"Stettler, K. et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353, 823\u2013826 (2016)","journal-title":"Science"},{"key":"BFnature20564_CR11","doi-asserted-by":"publisher","first-page":"e01123","DOI":"10.1128\/mBio.01123-16","volume":"7","author":"JA Swanstrom","year":"2016","unstructured":"Swanstrom, J. A. et al. Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against Zika virus. MBio 7, e01123\u201316 (2016)","journal-title":"MBio"},{"key":"BFnature20564_CR12","doi-asserted-by":"publisher","first-page":"e1003312","DOI":"10.1371\/journal.ppat.1003312","volume":"9","author":"P Pal","year":"2013","unstructured":"Pal, P. et al. Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus. PLoS Pathog. 9, e1003312 (2013)","journal-title":"PLoS Pathog."},{"key":"BFnature20564_CR13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1056\/NEJMcibr1605445","volume":"375","author":"IU Mysorekar","year":"2016","unstructured":"Mysorekar, I. U. & Diamond, M. S. Modeling Zika virus infection in pregnancy. N. Engl. J. Med. 375, 481\u2013484 (2016)","journal-title":"N. Engl. J. Med."},{"key":"BFnature20564_CR14","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.cell.2016.05.008","volume":"165","author":"JJ Miner","year":"2016","unstructured":"Miner, J. J. et al. Zika virus infection during pregnancy in mice causes placental damage and fetal demise. Cell 165, 1081\u20131091 (2016)","journal-title":"Cell"},{"key":"BFnature20564_CR15","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.cell.2016.08.004","volume":"166","author":"LJ Yockey","year":"2016","unstructured":"Yockey, L. J. et al. Vaginal exposure to Zika virus during pregnancy leads to fetal brain infection. Cell 166, 1247\u20131256.e4 (2016)","journal-title":"Cell"},{"key":"BFnature20564_CR16","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.4049\/jimmunol.0803247","volume":"182","author":"J Kim","year":"2009","unstructured":"Kim, J. et al. FcRn in the yolk sac endoderm of mouse is required for IgG transport to fetus. J. Immunol. 182, 2583\u20132589 (2009)","journal-title":"J. Immunol."},{"key":"BFnature20564_CR17","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/bdrb.20201","volume":"86","author":"N Pent\u0161uk","year":"2009","unstructured":"Pent\u0161uk, N. & van der Laan, J. W. An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testing of monoclonal antibodies. Birth Defects Res. B Dev. Reprod. Toxicol. 86, 328\u2013344 (2009)","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"BFnature20564_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.chom.2007.03.002","volume":"1","author":"TC Pierson","year":"2007","unstructured":"Pierson, T. C. et al. The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection. Cell Host Microbe 1, 135\u2013145 (2007)","journal-title":"Cell Host Microbe"},{"key":"BFnature20564_CR19","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/ni.3515","volume":"17","author":"W Dejnirattisai","year":"2016","unstructured":"Dejnirattisai, W. et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus. Nat. Immunol. 17, 1102\u20131108 (2016)","journal-title":"Nat. Immunol."},{"key":"BFnature20564_CR20","first-page":"1","volume":"8","author":"AS Charles","year":"2016","unstructured":"Charles, A. S. & Christofferson, R. C. Utility of a dengue-derived monoclonal antibody to enhance Zika infection in vitro . PLoS Curr. 8, 1\u201331 (2016)","journal-title":"PLoS Curr."},{"key":"BFnature20564_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature06106","volume":"449","author":"AJ Hessell","year":"2007","unstructured":"Hessell, A. J. et al. Fc receptor but not complement binding is important in antibody protection against HIV. Nature 449, 101\u2013104 (2007)","journal-title":"Nature"},{"key":"BFnature20564_CR22","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nm1240","volume":"11","author":"T Oliphant","year":"2005","unstructured":"Oliphant, T. et al. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat. Med. 11, 522\u2013530 (2005)","journal-title":"Nat. Med."},{"key":"BFnature20564_CR23","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3201\/eid1705.101939","volume":"17","author":"BD Foy","year":"2011","unstructured":"Foy, B. D. et al. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg. Infect. Dis. 17, 880\u2013882 (2011)","journal-title":"Emerg. Infect. Dis."},{"key":"BFnature20564_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-1-4939-0354-2_11","volume":"1140","author":"CA Nelson","year":"2014","unstructured":"Nelson, C. A., Lee, C. A. & Fremont, D. H. Oxidative refolding from inclusion bodies. Methods Mol. Biol. 1140, 145\u2013157 (2014)","journal-title":"Methods Mol. Biol."},{"key":"BFnature20564_CR25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jim.2008.04.008","volume":"336","author":"X Yu","year":"2008","unstructured":"Yu, X., McGraw, P. A., House, F. S. & Crowe, J. E., Jr. An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies. J. Immunol. Methods 336, 142\u2013151 (2008)","journal-title":"J. Immunol. Methods"},{"key":"BFnature20564_CR26","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1172\/JCI69377","volume":"123","author":"NJ Thornburg","year":"2013","unstructured":"Thornburg, N. J. et al. Human antibodies that neutralize respiratory droplet transmissible H5N1 influenza viruses. J. Clin. Invest. 123, 4405\u20134409 (2013)","journal-title":"J. Clin. Invest."},{"key":"BFnature20564_CR27","doi-asserted-by":"publisher","first-page":"W503","DOI":"10.1093\/nar\/gkn316","volume":"36","author":"X Brochet","year":"2008","unstructured":"Brochet, X., Lefranc, M.-P. & Giudicelli, V. IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 36, W503\u2013W508 (2008)","journal-title":"Nucleic Acids Res."},{"key":"BFnature20564_CR28","doi-asserted-by":"crossref","unstructured":"Giudicelli, V. & Lefranc, M. P. IMGT\/junctionanalysis: IMGT standardized analysis of the V-J and V-D-J junctions of the rearranged immunoglobulins (Ig) and T cell receptors (TR). Cold Spring Harb. Protoc. 2011, 716\u2013725 (2011)","DOI":"10.1101\/pdb.prot5634"},{"key":"BFnature20564_CR29","doi-asserted-by":"publisher","first-page":"e1003157","DOI":"10.1371\/journal.ppat.1003157","volume":"9","author":"KL Williams","year":"2013","unstructured":"Williams, K. L. et al. Therapeutic efficacy of antibodies lacking Fc\u03b3R against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing Antibodies. PLoS Pathog. 9, e1003157 (2013)","journal-title":"PLoS Pathog."},{"key":"BFnature20564_CR30","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1172\/JCI85317","volume":"126","author":"NJ Thornburg","year":"2016","unstructured":"Thornburg, N. J. et al. H7N9 influenza virus neutralizing antibodies that possess few somatic mutations. J. Clin. Invest. 126, 1482\u20131494 (2016)","journal-title":"J. Clin. Invest."},{"key":"BFnature20564_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nmeth.1318","volume":"6","author":"DG Gibson","year":"2009","unstructured":"Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6, 343\u2013345 (2009)","journal-title":"Nat. Methods"},{"key":"BFnature20564_CR32","doi-asserted-by":"publisher","first-page":"14364","DOI":"10.1128\/JVI.01943-14","volume":"88","author":"RH Fong","year":"2014","unstructured":"Fong, R. H. et al. Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy. J. Virol. 88, 14364\u201314379 (2014)","journal-title":"J. Virol."},{"key":"BFnature20564_CR33","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3201\/eid1408.080287","volume":"14","author":"RS Lanciotti","year":"2008","unstructured":"Lanciotti, R. S. et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg. Infect. Dis. 14, 1232\u20131239 (2008)","journal-title":"Emerg. Infect. Dis."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature20564.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature20564","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature20564.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:57:44Z","timestamp":1684418264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature20564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,7]]},"references-count":33,"journal-issue":{"issue":"7633","published-print":{"date-parts":[[2016,12,15]]}},"alternative-id":["BFnature20564"],"URL":"https:\/\/doi.org\/10.1038\/nature20564","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726933960.793525282","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,7]]},"assertion":[{"value":"3 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.L.B., T.B., E.D. and B.J.D. are employees of Integral Molecular. B.J.D. is a shareholder of Integral Molecular. M.S.D. is a consultant for Inbios, Visterra, and Takeda Pharmaceuticals, and on the Scientific Advisory Boards of Moderna and OraGene. J.E.C. is a consultant for Sanofi and Ridgeback Biotherapeutics, is on the Scientific Advisory Boards of PaxVax, CompuVax, GigaGen, Meissa Vaccines, and is a recipient of research grants from Moderna and Sanofi.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}